University of Hasanuddin Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Makassar Indonesia (1956)

Organization Overview

First Clinical Trial
2014
NCT01999686
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bumi Herman | Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hasanuddin, Dr. Wahidin Sudirohusodo Hospital, Makasar, Indonesia. | Hasanuddin University

Active Ingredients

Drugs in Phase 4 Trials (4)

dextrose (3 trials)

hyaluronic acid (1 trial)

rillus (1 trial)

sodium chloride (1 trial)

Drugs in Phase 3 Trials (3)

dlbs3233 (1 trial)

sitagliptin (januvia) (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 2 Trials (1)

eucalyptus oil (1 trial)

Drugs in Phase 1 Trials (1)

pumpkin seed extract (1 trial)

Drugs in Other Trials (7)

beta carotene (solatene) (1 trial)

cow milk (1 trial)

oryza sativa (1 trial)

piper crocatum (1 trial)

trichloroacetic acid (1 trial)

vitamin c (1 trial)

zinc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Insulin Resistance (Phase 4)

Obesity (Phase 4)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Polycystic Ovary Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 15
  • # of Trial APIs: 16